Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissuedisease

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 593-598

  Naniwa, Taio ^a   Sugiura, Yoshiki ^b   Banno, Shogo ^a   Yoshinouchi, Takeo ^c   Matsumoto, Yoshifuji ^d   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^b Sugiura Medical Clinic   (Japan)

^c Toyokawa City Hospital   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Autoantibodies; cDNA library; Endothelial cells; Enzyme linked immunosorbent assay; Immunoassay; Mixed connective tissue disease; Ribosomal protein PO

Indexed keywords

AUTOANTIGEN; ENDOTHELIAL CELL ANTIBODY; LA ANTIBODY; LA ANTIGEN; MESSENGER RNA; PROTEIN P0; RIBOSOME PROTEIN; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DNA LIBRARY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SYSTEMIC SCLEROSIS; UMBILICAL VEIN;

ADULT; ANTIGENS; AUTOANTIBODIES; AUTOANTIGENS; CLONING, MOLECULAR; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; ONCOGENES; RIBONUCLEOPROTEINS; RIBOSOMAL PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 34648825071     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. SHARP GC, SINGSEN BM: Mixed connective tissue disease. In MC CARTY DJ and KOOPMAN WJ (Eds.): Arthritis and Allied Conditions, 12th ed., Philadelphia and London, Lea & Febiger, 1993: 1213-24.
2. MERONI PL, YOUINOU P: Endothelial cell autoantibodies. In PETER JB and SHOENFELD Y (Eds.): Autoantibodies, Amsterdam, Elsevier Science, 1996: 245-52.
3. VAN DER ZEE JM, SIEGERT CE, DE VREEDE TA, DAHA MR, BREEDVELD FC: Characterization of anti-endothelial cell antibodies in systemic lupus erythernatosus (SLE). Clin Exp Immunol 1991; 84: 238-44.
4. RENAUDINEAU Y, REVELEN R, LEVY Y et al.: Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 1999; 6: 156-60.
5. FERRARO G, MERONI PL, TINCANI A et al.: Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 47-53.
6. PARK MC, PARK YB, JUNG SY, LEE KH, LEE SK: Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: Correlations of their titers and isotype distributions with disease activity. Clin Exp Rheumatol 2006; 24 (Suppl. 41): S10-16.
7. CARVALHO D, SAVAGE COS, BLACK CM, PEARSON JD: IgG autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996; 97: 111-9.
8. BODOLAY E, CSIPO I, GAL I et al.: Anti-endothelial cell antibodies in mixed connective tissue disease: Frequency and association with clinical symptoms. Clin Exp Rheumatol 2004; 22: 409-15.
9. VEGH J, SZODORAY P, KAPPELMAYER J et al.: Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol 2006; 64: 69-76.
10. KASUKAWA R, TOJO T, MIYAWAKI S: Preliminary diagnostic criteria for classification of mixed connective tissue disease. In KASUKAWA R and SHARP GC (Eds.): Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam, Elsevier; 1987: 41-4.
11. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
12. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
13. ELKON KB, PARNASSA AP, FOSTER CL: Lupus autoantibodies target ribosomal P proteins. J Exp Med 1985; 162: 459-71.
14. ELKON K, SKELLY S, PARNASSA A et al.: Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1986; 83: 7419-23.
15. GERLI R, CAPONI L: Anti-ribosomal P protein antibodies. Autoimmunity 2005; 38: 85-92.
16. DONG X, MICHELIS MA, WANG J, BOSE R, DELANGE T, REEVES WH: Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis. Arthritis Rheum 1998; 41: 1505-10.
17. WICHMANN I, GARCIA-LOZANO JR, RESPALDIZA N, GONZALEZ-ESCRIBANO MF, NUNEZ-ROLDAN A: Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus. Hum Immunol 1999; 60: 57-62.
18. STURGESS AD, PETERSON MG, MCNEILAGE IJ, WHITTINGHAM S, COPPEL RL: Characteristics and epitope mapping of a cloned human autoantigen La. J Immunol 1988; 140: 3212-8.
19. PETTERSSON I, WANG G, SMITH EI et al.: The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum 1986; 29: 986-96.
20. JEOUNG DI, BONG LEE E, LEE S et al.: Antoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis. Biochem Biophys Res Commun 2002; 299: 549-54.
21. FRAMPTON G, MORIYA S, PEARSON JD et al.: Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: A role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology (Oxford) 2000; 39: 1114-20.
22. KOREN E, REICHLIN MW, KOSCEC M, FUGATE RD, REICHLIN M: Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-41.
23. SUN KH, LIU WT, TSAI CY, TANG SJ, HAN SH, YU CL: Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology 1995; 85: 262-9.
24. STAFFORD HA, CHEN AE, ANDERSON CJ et al.: Anti-ribosomal and 'P-peptide'-specific autoantibodies bind to T lymphocytes. Clin Exp Immunol 1997; 109: 12-9.
25. YOSHIO T, MASUYAMA J, KANO S: Anti-ribosomal PO protein antibodies react with the surface of human umbilical vein endothelial cells. J Rheumatol 1996; 23: 1311-2.
26. STACEY DW, SKELLY S, WATSON T, ELKON K, WEISSBACH H, BROT N: The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients. Arch Biochem Biophys 1988; 267: 398-403.
27. SUN KH, TANG SJ, LIN ML, WANG YS, SUN GH, LIU WT: Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology (Oxford) 2001; 40: 750-6.